^
    BIOMARKER:

    NTRK2 fusion

    i
    Other names: NTRK2, TRKB, Neurotrophic tyrosine kinase, receptor, type 2




    Show legend

    Include preclinical:
    Solid Tumor
    Biliary Tract Cancer
    Non Small Cell Lung Cancer
    Colorectal Cancer
    Glioma
    Pancreatic Cancer
    Gastrointestinal Stromal Tumor
    Thyroid Gland Papillary Carcinoma
    Soft Tissue Sarcoma
    Gastroesophageal Junction Adenocarcinoma
    Esophageal Cancer
    Cervical Cancer
    Breast Cancer
    Hepatocellular Cancer
    Ovarian Cancer
    Thyroid Gland Anaplastic Carcinoma
    Salivary Gland Cancer
    Endometrial Cancer
    Colon Cancer
    Gastric Cancer
    Thyroid Gland Hurthle Cell Carcinoma
    Cutaneous Melanoma
    Pancreatic Adenocarcinoma
    Rectal Cancer
    Vulvar Cancer
    Glioblastoma
    Neuroendocrine Tumor
    Ampulla of Vater Carcinoma
    Cholangiocarcinoma
    Thyroid Gland Carcinoma
    Small Intestinal Carcinoma
    Thyroid Gland Follicular Carcinoma
    Peritoneal Cancer
    Fallopian Tube Cancer
    Sarcoma
    Melanoma
    Fibrosarcoma
    Small Cell Lung Cancer
    Osteosarcoma
    Gastrointestinal Cancer
    Lung Cancer
    Esophageal Squamous Cell Carcinoma
    CNS Tumor
    larotrectinib
    entrectinib
    Trk inhibitor
    Immunotherapy
    repotrectinib
    ICP-723
    entrectinib + abemaciclib
    SIM1803-1A
    durvalumab
    trametinib + entrectinib